Skip to content
AI IntelligenceNov 12, 2026AI Intelligence
Article

Google DeepMind unveiled AlphaGenome 2, which analyzes genetic variants at individual cell type resolution rather than across bulk tissue.

Trained on more than 107 million cell profiles, it identifies nearly twice as many disease-relevant gene changes as its predecessor. The model is available for noncommercial research via API and is set to be integrated into Google's Antigravity platform.

AI-generated: summaries written by AI from the linked sources. How we use AI

AI-generatedSource: The Decoder
01

Source Brief

Google DeepMind unveiled AlphaGenome 2, which analyzes genetic variants at individual cell type resolution rather than across bulk tissue. Trained on more than 107 million cell profiles, it identifies nearly twice as many disease-relevant gene changes as its predecessor. The model is available for noncommercial research via API and is set to be integrated into Google's Antigravity platform.